324 related articles for article (PubMed ID: 29728406)
21. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
Immunol Allergy Clin North Am; 2010 Feb; 30(1):17-30. PubMed ID: 20113884
[TBL] [Abstract][Full Text] [Related]
22. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
[TBL] [Abstract][Full Text] [Related]
23. Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?
Laberko A; Gennery AR
Expert Rev Clin Immunol; 2015; 11(7):785-8. PubMed ID: 26099343
[TBL] [Abstract][Full Text] [Related]
24. Human lymphoid development in the absence of common γ-chain receptor signaling.
Kohn LA; Seet CS; Scholes J; Codrea F; Chan R; Zaidi-Merchant S; Zhu Y; De Oliveira S; Kapoor N; Shah A; Abdel-Azim H; Kohn DB; Crooks GM
J Immunol; 2014 Jun; 192(11):5050-8. PubMed ID: 24771849
[TBL] [Abstract][Full Text] [Related]
25. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort.
Lankester AC; Neven B; Mahlaoui N; von Asmuth EGJ; Courteille V; Alligon M; Albert MH; Serra IB; Bader P; Balashov D; Beier R; Bertrand Y; Blanche S; Bordon V; Bredius RG; Cant A; Cavazzana M; Diaz-de-Heredia C; Dogu F; Ehlert K; Entz-Werle N; Fasth A; Ferrua F; Ferster A; Formankova R; Friedrich W; Gonzalez-Vicent M; Gozdzik J; Güngör T; Hoenig M; Ikinciogullari A; Kalwak K; Kansoy S; Kupesiz A; Lanfranchi A; Lindemans CA; Meisel R; Michel G; Miranda NAA; Moraleda J; Moshous D; Pichler H; Rao K; Sedlacek P; Slatter M; Soncini E; Speckmann C; Sundin M; Toren A; Vettenranta K; Worth A; Yeşilipek MA; Zecca M; Porta F; Schulz A; Veys P; Fischer A; Gennery AR
J Allergy Clin Immunol; 2022 May; 149(5):1744-1754.e8. PubMed ID: 34718043
[TBL] [Abstract][Full Text] [Related]
27. T
Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
[TBL] [Abstract][Full Text] [Related]
28. Il2rg gene-targeted severe combined immunodeficiency pigs.
Suzuki S; Iwamoto M; Saito Y; Fuchimoto D; Sembon S; Suzuki M; Mikawa S; Hashimoto M; Aoki Y; Najima Y; Takagi S; Suzuki N; Suzuki E; Kubo M; Mimuro J; Kashiwakura Y; Madoiwa S; Sakata Y; Perry ACF; Ishikawa F; Onishi A
Cell Stem Cell; 2012 Jun; 10(6):753-758. PubMed ID: 22704516
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
[TBL] [Abstract][Full Text] [Related]
30. Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning.
Huston MW; van Til NP; Visser TP; Arshad S; Brugman MH; Cattoglio C; Nowrouzi A; Li Y; Schambach A; Schmidt M; Baum C; von Kalle C; Mavilio F; Zhang F; Blundell MP; Thrasher AJ; Verstegen MM; Wagemaker G
Mol Ther; 2011 Oct; 19(10):1867-77. PubMed ID: 21750532
[TBL] [Abstract][Full Text] [Related]
31. The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency.
Serana F; Sottini A; Chiarini M; Zanotti C; Ghidini C; Lanfranchi A; Notarangelo LD; Caimi L; Imberti L
J Immunol; 2010 Dec; 185(12):7713-22. PubMed ID: 21057082
[TBL] [Abstract][Full Text] [Related]
32. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing of T
El Hawary R; Meshaal S; Mauracher AA; Opitz L; Abd Elaziz D; Lotfy S; Eldash A; Boutros J; Galal N; Pachlopnik Schmid J; Elmarsafy A
Clin Exp Immunol; 2021 Mar; 203(3):448-457. PubMed ID: 33040328
[TBL] [Abstract][Full Text] [Related]
34. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
[TBL] [Abstract][Full Text] [Related]
35. Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation.
Dvorak CC; Hung GY; Horn B; Dunn E; Oon CY; Cowan MJ
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1125-1133. PubMed ID: 18804042
[TBL] [Abstract][Full Text] [Related]
36. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
37. Use of TCR α
Brettig T; Smart J; Choo S; Mechinaud F; Mitchell R; Raj TS; Cole T
J Clin Immunol; 2019 Jul; 39(5):505-511. PubMed ID: 31172381
[TBL] [Abstract][Full Text] [Related]
38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
